Come up with a name for your new list and we'll add to it:
Sigilon Therapeutics raised a round of funding on April 04, 2018. Investors include
Eli Lilly & Co..
Sigilon Therapeutics discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and biocompatible Afibromer …